Skip to content
Screener

Ionis Pharmaceuticals IONS Segment Reporting, Other Segment Item, Amount

Segment Reporting, Other Segment Item, Amount at other companies

PRA Group logo
PRA GroupPRAA
$35.48M-6.5%
ConocoPhillips logo
ConocoPhillipsCOP
$7.45B+42.3%
Matthews International logo
Matthews InternationalMATW
-$15.63M-883%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$25.48M+4,316%
Radiant Logistics logo
Radiant LogisticsRLGT
-$271K-113%
Microbot Medical logo
Microbot MedicalMBOT
$557K+7.3%

Segments

By segment

See full
Ionis Operations$57.95M+26.1%

Other financials

Income statement

See full
Revenue$267.9M-40.7%
Gross profit$265.2M-40.8%
Operating income-$102.3M-173%
Net income-$114.6M-193%
EPS (diluted)-$0.69-199%

Balance sheet

See full
Cash & equivalents$350.1M+17.7%
Total debt$262.5M-67.0%
Total equity$439.7M-30.4%
Total assets$3.0B+0.3%

Cash flow

See full
Operating cash flow-$792.8M-426%
CapEx$16.1M+30.7%
Free cash flow-$814.6M-399%

Valuation

See full
Market cap$9.01B+38.9%
Enterprise value$8.92B+27.7%
P/S10.3×+3.4×

Profitability

See full
Gross margin98.2%-0.7pp
Operating margin-68%-234pp
Net margin-64.7%-299pp
FCF margin-77.4%+35.3pp

Returns & leverage

See full
Return on equity-105.5%+336pp
Debt / equity0.6×-0.7×
Current ratio7.9×+5.0×